FOLH1 and posterior cortical atrophy: The present study suggests that neuroendocrine differentiation may not be the unique aggressive low-PSMA expressing variant of PCa, and that the downregulation of plasma membrane PSMA docking may represent a post-transcriptional source of heterogeneity at PSMA PET imaging, coherently with previous data [50].